Junior Resident, Department of Medicine, Gandhi Medical College, Bhopal, Madhya Pradesh, India.
Associate Professor, Department of Medicine, Gandhi Medical College, Bhopal, Madhya Pradesh, India.
J Assoc Physicians India. 2023 Nov;71(11):25-29. doi: 10.59556/japi.71.0382.
: Studies have shown that high-resolution computed tomography (HRCT) of the chest along with clinical parameters is useful in determining the clinical progression, extent of disease and severity of illness in patients with COVID-19. Hence, the present study was done to assess HRCT chest features in patients with COVID-19 infection and to find its association with clinical status in these cases. : This was an observational study over the period of 18 months in patients diagnosed with COVID-19 disease following reverse transcription polymerase chain reaction (RT-PCR). Demographic details, history, clinical parameters, blood and imaging details of enrolled patients were recorded in the study proforma and analyzed using Statistical Package for the Social Sciences (SPSS) software for Windows. : The study included 150 COVID-19 patients. HRCT chest severity score was mild in the majority of patients (46.7%), moderate in 24.7%, severe in 5.3%, and negative in 23.3% of cases. HRCT chest severity score was directly correlated with fever, dyspnea, cough, sore throat, reduced appetite, tachypnea, tachycardia, heart rate, respiratory rate, systolic blood pressure, peripheral oxygen saturation, and Glasgow Coma Scale (GCS) score ( < 0.05). : The HRCT chest severity score is directly correlated with clinical symptoms, clinical parameters, coexisting comorbidities, and radiological findings in patients with COVID-19 disease. Hence, HRCT chest plays an important role in assessing the severity of COVID-19 disease and predicting the outcome in these patients. : Verma S, Sejwar A, Dube S, Correlation of Clinical Parameters with Findings of High-resolution Computed Tomography Chest in COVID-19 Patients. J Assoc Physicians India 2023;71(11):25-29.
研究表明,胸部高分辨率计算机断层扫描(HRCT)结合临床参数可用于确定 COVID-19 患者的临床进展、疾病范围和疾病严重程度。因此,本研究旨在评估 COVID-19 感染患者的 HRCT 胸部特征,并发现其与这些患者临床状况的关系。
这是一项为期 18 个月的观察性研究,对经逆转录聚合酶链反应(RT-PCR)诊断为 COVID-19 疾病的患者进行研究。研究方案中记录了患者的人口统计学细节、病史、临床参数、血液和影像学详细信息,并使用 Windows 版社会科学统计软件包(SPSS)进行分析。
该研究纳入了 150 例 COVID-19 患者。大多数患者的 HRCT 胸部严重程度评分为轻度(46.7%),中度为 24.7%,重度为 5.3%,阴性为 23.3%。HRCT 胸部严重程度评分与发热、呼吸困难、咳嗽、咽痛、食欲不振、呼吸急促、心动过速、心率、呼吸频率、收缩压、外周血氧饱和度和格拉斯哥昏迷评分(GCS)评分呈直接相关(<0.05)。
HRCT 胸部严重程度评分与 COVID-19 患者的临床症状、临床参数、并存的合并症和影像学发现直接相关。因此,HRCT 胸部在评估 COVID-19 疾病的严重程度和预测这些患者的结局方面发挥着重要作用。
Verma S、Sejwar A、Dube S,《COVID-19 患者的临床参数与高分辨率计算机断层扫描胸部结果的相关性》,《印度医师协会杂志》2023 年 71 卷第 11 期 25-29 页。